- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04245020
A Study Comparing Three Methods of Outpatient Follow up After Surgical Admission; Text Message, Phone Call and In-person Appointment (ISOTOPE)
An Open Label Randomised Control Trial Comparing Three Methods of Outpatient Follow up After Surgical Admission in Connolly Hospital Blanchardstown; Text Message, Phone Call and In-person Appointment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a non-blinded, single centre open randomised control trial of the outpatient follow up method following surgical admission to Connolly Hospital Blanchardstown.
All eligible patients will be randomised into three arms, text message, telephone or in-person follow up. The follow up will be carried out at 6-8 weeks following discharge. The rate of complications, the non-response rate and the level of satisfaction will be compared between the three groups.
Willingness to use a telemedicine app in the future in place of an in-person follow up will also be measured by patient satisfaction questionnaire.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Co. Dublin
-
Dublin 15, Co. Dublin, Ireland, D07 A59E
- Connolly Hospital Blanchardstown
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Surgical patients admitted either as an emergency or for an elective procedure
- 16 years or older
Exclusion Criteria:
- Did not consent or cannot give consent
- Age less than 16
- No smartphone
- Further follow up required for treatment of further investigation
- Diagnosis or suspected diagnosis of malignancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Text Message
Patients will be followed up with a series of text messages at 6-8 weeks
|
A text message will be sent to the patient 6-8 weeks following discharge
|
|
Active Comparator: Telephone
Patients will be followed with a telephone conversation at 6-8 weeks
|
The patient will be followed up at 6-8 weeks following discharge with a telephone call
|
|
Active Comparator: In person
Patients will be followed in person in the Outpatient department at 6-8 weeks
|
The patient will be followed up at 6-8 weeks following discharge in person in the outpatient department
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications that require further follow up
Time Frame: 6-8 weeks
|
Complications are identified by patient record and follow up method selected
|
6-8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction in follow up
Time Frame: 8-10 weeks
|
A questionnaire will assess how happy based on a survey patients were with their follow up method.
The CSQ 8 score will be used along with a previously published questionnaire from this institiution.
In the CSQ-8 questionnaire a higher score indicates more satisfaction.
|
8-10 weeks
|
|
Willingness to use a virtual clinic app in the future
Time Frame: 8-10 weeks
|
A questionnaire will assess patients preference in further follow up, specifically are patients happy to use a telemedicine based app.
(answer no definitely not, no not really, yes generally, yes definitely.
|
8-10 weeks
|
|
Follow up preference
Time Frame: 8-10 weeks
|
Preferred follow up method will be identified by above patient questionnaire (text, phone or OPD)
|
8-10 weeks
|
|
Lost to follow up
Time Frame: 6-8 weeks
|
number of patients that are lost to follow up per follow up method
|
6-8 weeks
|
|
Further procedures arranged
Time Frame: 8-10 weeks
|
number of patients who have an additional procedure arranged which will be identified in the medical record
|
8-10 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Paul M Cromwell, BM BS BA MRCS, Department of Surgery, Connolly Hospital Blanchardstown, Dublin 15
- Study Chair: Thomas N Walsh, MD MCh FRCSI, Department of Surgery, Connolly Hospital Blanchardstown, Dublin 15
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ISOTOPE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.